Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.390
-0.080 (-5.44%)
Mar 31, 2025, 9:47 AM EDT - Market open
Atai Life Sciences Revenue
In the year 2024, Atai Life Sciences had annual revenue of $308.00K, down -1.91%. Atai Life Sciences had revenue of $-5.00K in the quarter ending December 31, 2024, a decrease of -127.78%.
Revenue (ttm)
$308.00K
Revenue Growth
-1.91%
P/S Ratio
946.46
Revenue / Employee
$5,704
Employees
54
Market Cap
275.65M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ATAI News
- 20 days ago - atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression - GlobeNewsWire
- 4 weeks ago - Atai: Following The Path That Spravato Laid And Moving Beyond It - Seeking Alpha
- 4 weeks ago - atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - GlobeNewsWire
- 6 weeks ago - atai Life Sciences Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
- 6 weeks ago - atai Life Sciences Announces Proposed Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - Atai Life Sciences: Positive BPL-003 Data In AUD Leads To Another Catalyst - Seeking Alpha
- 2 months ago - atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health - GlobeNewsWire